» Articles » PMID: 25431776

Surgical Treatment of Perianal Fistulizing Crohn's Disease: from Lay-open to Cell-based Therapy--an Overview

Overview
Publisher Wiley
Specialty Biology
Date 2014 Nov 29
PMID 25431776
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Perianal Crohn's disease (CD) can be challenging. Despite the high incidence of fistulizing CD, literature lacks clear guidelines. Several medical, surgical, and combined treatment modalities have been proposed, but evidences are scarce.

Methods: We searched the literature to assess the facets of perianal CD, with particular focus on complex fistulae. Disease epidemiology, classification, diagnosis, activity scoring systems, and medical-surgical treatments were assessed.

Results: Perianal fistulizing CD is common, frequently associated with upper gastrointestinal and colorectal CD. Complex fistulas often require repeated treatments. Continence is a major concern when dealing with repeated procedures. A prudent pathway is to resolve active sepsis and to limit damages, delaying a definitive treatment to the time when acute phase has been controlled. The improved diagnostic techniques allow better preoperative planning and are useful in monitoring the response to treatment. Besides newer devices, cell-based treatments are promising tools which have recently enriched the treatment portfolio. However, the need for proctectomy is still disturbingly high in CD patients with complex perianal fistulae.

Conclusions: Perianal CD can impair quality of life and lead to need for proctectomy. A staged approach is reasonable. Treatment success can be improved by multimodal treatment and collaborative management by experienced gastroenterologists and surgeons.

Citing Articles

Current review of the management of fistulising perianal Crohn's disease.

Adegbola S, Sahnan K, Twum-Barima C, Iqbal N, Reza L, Lung P Frontline Gastroenterol. 2021; 12(6):515-523.

PMID: 34712470 PMC: 8515276. DOI: 10.1136/flgastro-2020-101489.


Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.

Pellino G, Keller D, Sampietro G, Angriman I, Carvello M, Celentano V Tech Coloproctol. 2020; 24(5):421-448.

PMID: 32172396 DOI: 10.1007/s10151-020-02183-z.


Medical and surgical management of perianal Crohn's disease.

Adegbola S, Pisani A, Sahnan K, Tozer P, Ellul P, Warusavitarne J Ann Gastroenterol. 2018; 31(2):129-139.

PMID: 29507460 PMC: 5825943. DOI: 10.20524/aog.2018.0236.


Fistulizing Crohn's Disease.

Scharl M, Rogler G, Biedermann L Clin Transl Gastroenterol. 2017; 8(7):e106.

PMID: 28703786 PMC: 5539341. DOI: 10.1038/ctg.2017.33.


Management of complex perianal Crohn's disease.

Aguilera-Castro L, Ferre-Aracil C, Garcia-Garcia-de-Paredes A, Rodriguez-de-Santiago E, Lopez-Sanroman A Ann Gastroenterol. 2017; 30(1):33-44.

PMID: 28042236 PMC: 5198245. DOI: 10.20524/aog.2016.0099.


References
1.
Grimaud J, Munoz-Bongrand N, Siproudhis L, Abramowitz L, Senejoux A, Vitton V . Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. Gastroenterology. 2010; 138(7):2275-81, 2281.e1. DOI: 10.1053/j.gastro.2010.02.013. View

2.
Gingold D, Murrell Z, Fleshner P . A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn's disease. Ann Surg. 2013; 260(6):1057-61. DOI: 10.1097/SLA.0000000000000479. View

3.
Irvine E . Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol. 1995; 20(1):27-32. View

4.
Poggioli G, Laureti S, Pierangeli F, Bazzi P, Coscia M, Gentilini L . Local injection of adalimumab for perianal Crohn's disease: better than infliximab?. Inflamm Bowel Dis. 2010; 16(10):1631. DOI: 10.1002/ibd.21210. View

5.
Parks A, Gordon P, Hardcastle J . A classification of fistula-in-ano. Br J Surg. 1976; 63(1):1-12. DOI: 10.1002/bjs.1800630102. View